Overview
Sponsor-declared trial summary
Phase
Human pharmacology (Phase I) - Other
Status
Ended
Participants planned
40
Countries
1
Sites
1
not applicable (submitted trial is a pharmacokinetic and pharmacodynamic safety study in healthy subjects)
Key facts
- Sponsor
- Rhoshan Pharmaceuticals Inc.
- Participant type
- Healthy volunteers
- Age range
- 18-64 years
- Gender
- Male and Female
- Therapeutic area
- Diseases [C] - Hemic and Lymphatic Diseases [C15]
- Trial duration
- 4 Jun 2025 → 14 Jul 2025
- Decision date (initial)
- 2025-06-03
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- Yes
Trial design
CTIS Part I — objectives, methods, condition coding
Conditions and MedDRA coding
not applicable (submitted trial is a pharmacokinetic and pharmacodynamic safety study in healthy subjects)
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
Rhoshan Pharmaceuticals Inc.
- Sponsor organisation
- Rhoshan Pharmaceuticals Inc.
- Address
- 2472 Pine Hurst Court
- City
- State College
- Postcode
- 16803-3394
- Country
- United States
Scientific contact point
- Organisation
- Rhoshan Pharmaceuticals Inc.
- Contact name
- JOSEPH PURVIS, MD
Public contact point
- Organisation
- Rhoshan Pharmaceuticals Inc.
- Contact name
- HITHA PALEPU
Locations
1 EU/EEA country · 1 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| Czechia | Ended | 40 | 1 |
| Rest of world | — | 0 | — |
Investigational sites
Country notifications
Trial-start, recruitment-start, end and early-termination notifications submitted per Member State
| Country | Trial start | Trial end | Recruitment start | Recruitment end | Early termination |
|---|---|---|---|---|---|
| Czechia | 2025-06-04 | 2025-07-14 | 2025-06-04 | 2025-06-23 |
Application history
1 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2025-04-22 | Czechia | Acceptable 2025-06-03
|
2025-06-03 |